Financial insights of SYRE

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue-Development Fee And Royalty	-	0*	-	-
Total revenue	-	0*	-	-
Research and development	60,411	98,150*	45,247	40,145
General and administrative	15,230	12,763*	11,641	11,790
Acquired in-process research and development	-	0*	-	-
Loss on sale of in-process research and development asset	30,000	-5,000*	0	10,000
Total operating expenses	45,641	115,912*	56,888	41,935
Loss from operations	-45,641	-115,912*	-56,888	-41,935
Interest income	6,995	8,006*	5,379	5,874
Change in fair value of forward contract liability-Forward Contracts	-	0*	-	-
Other (expense) income, net	-30,359	-30,045*	40,326	-656
Total other (expense) income	-23,364	-22,040*	45,705	5,218
Loss before income tax expense	-69,005	-137,953*	-11,183	-36,717
Income tax benefit	0	-15*	0	0
Net loss	-69,005	-137,938	-11,183	-327

Basic EPS	-29.66	-398.613	-5.97	-19.62
Diluted EPS	-29.66	-398.613	-5.97	-19.62
Basic Average Shares	346,045	346,045*	346,045	16,667
Diluted Average Shares	346,045	346,045*	346,045	16,667

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.